211 related articles for article (PubMed ID: 33119958)
21. The current status and future directions of myxoma virus, a master in immune evasion.
Spiesschaert B; McFadden G; Hermans K; Nauwynck H; Van de Walle GR
Vet Res; 2011 Jun; 42(1):76. PubMed ID: 21658227
[TBL] [Abstract][Full Text] [Related]
22. Multi-event capture-recapture models estimate the diagnostic performance of serological tests for myxoma and rabbit haemorrhagic disease viruses in the absence of reference samples.
Pacheco H; Lopes AM; Bárcena J; Blanco E; Abrantes J; Esteves P; Choquet R; Alves PC; Santos N
Transbound Emerg Dis; 2022 Sep; 69(5):e3024-e3035. PubMed ID: 35810475
[TBL] [Abstract][Full Text] [Related]
23. Comparative analysis of the complete genome sequence of the California MSW strain of myxoma virus reveals potential host adaptations.
Kerr PJ; Rogers MB; Fitch A; Depasse JV; Cattadori IM; Hudson PJ; Tscharke DC; Holmes EC; Ghedin E
J Virol; 2013 Nov; 87(22):12080-9. PubMed ID: 23986601
[TBL] [Abstract][Full Text] [Related]
24. Coinfections of Novel Polyomavirus, Anelloviruses and a Recombinant Strain of Myxoma Virus-MYXV-Tol Identified in Iberian Hares.
Águeda-Pinto A; Kraberger S; Lund MC; Gortázar C; McFadden G; Varsani A; Esteves PJ
Viruses; 2020 Mar; 12(3):. PubMed ID: 32244962
[TBL] [Abstract][Full Text] [Related]
25. MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection.
Blanié S; Gelfi J; Bertagnoli S; Camus-Bouclainville C
Virol J; 2010 Mar; 7():56. PubMed ID: 20211013
[TBL] [Abstract][Full Text] [Related]
26. Disentangling synergistic disease dynamics: Implications for the viral biocontrol of rabbits.
Wells K; Fordham DA; Brook BW; Cassey P; Cox T; O'Hara RB; Schwensow NI
J Anim Ecol; 2018 Sep; 87(5):1418-1428. PubMed ID: 30133819
[TBL] [Abstract][Full Text] [Related]
27. Punctuated Evolution of Myxoma Virus: Rapid and Disjunct Evolution of a Recent Viral Lineage in Australia.
Kerr PJ; Eden JS; Di Giallonardo F; Peacock D; Liu J; Strive T; Read AF; Holmes EC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30728252
[TBL] [Abstract][Full Text] [Related]
28. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbits.
Mossman K; Nation P; Macen J; Garbutt M; Lucas A; McFadden G
Virology; 1996 Jan; 215(1):17-30. PubMed ID: 8553583
[TBL] [Abstract][Full Text] [Related]
29. Myxomatosis in Australia and Europe: a model for emerging infectious diseases.
Kerr PJ
Antiviral Res; 2012 Mar; 93(3):387-415. PubMed ID: 22333483
[TBL] [Abstract][Full Text] [Related]
30. The Dynamics of
Prenda J; Rodríguez-Rodríguez EJ; Negro JJ; Muñoz-Pichardo JM
Animals (Basel); 2022 May; 12(11):. PubMed ID: 35681816
[TBL] [Abstract][Full Text] [Related]
31. Molecular characterization of SG33 and Borghi vaccines used against myxomatosis.
Cavadini P; Botti G; Barbieri I; Lavazza A; Capucci L
Vaccine; 2010 Jul; 28(33):5414-20. PubMed ID: 20598407
[TBL] [Abstract][Full Text] [Related]
32. Myxoma virus M156 is a specific inhibitor of rabbit PKR but contains a loss-of-function mutation in Australian virus isolates.
Peng C; Haller SL; Rahman MM; McFadden G; Rothenburg S
Proc Natl Acad Sci U S A; 2016 Apr; 113(14):3855-60. PubMed ID: 26903626
[TBL] [Abstract][Full Text] [Related]
33. Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer.
Villa NY; Franco LS; McFadden G
Methods Mol Biol; 2020; 2058():95-110. PubMed ID: 31486033
[TBL] [Abstract][Full Text] [Related]
34. Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. III. Release, persistence and rate of spread of an identifiable strain of myxoma virus.
Merchant JC; Kerr PJ; Simms NG; Hood GM; Pech RP; Robinson AJ
Epidemiol Infect; 2003 Feb; 130(1):135-47. PubMed ID: 12613755
[TBL] [Abstract][Full Text] [Related]
35. Virulence and pathogenesis of the MSW and MSD strains of Californian myxoma virus in European rabbits with genetic resistance to myxomatosis compared to rabbits with no genetic resistance.
Silvers L; Inglis B; Labudovic A; Janssens PA; van Leeuwen BH; Kerr PJ
Virology; 2006 Apr; 348(1):72-83. PubMed ID: 16442580
[TBL] [Abstract][Full Text] [Related]
36. M148R and M149R are two virulence factors for myxoma virus pathogenesis in the European rabbit.
Blanié S; Mortier J; Delverdier M; Bertagnoli S; Camus-Bouclainville C
Vet Res; 2009; 40(1):11. PubMed ID: 19019281
[TBL] [Abstract][Full Text] [Related]
37. Pseudogenization of the MCP-2/CCL8 chemokine gene in European rabbit (genus Oryctolagus), but not in species of Cottontail rabbit (Sylvilagus) and Hare (Lepus).
van der Loo W; Afonso S; de Matos AL; Abrantes J; Esteves PJ
BMC Genet; 2012 Aug; 13():72. PubMed ID: 22894773
[TBL] [Abstract][Full Text] [Related]
38. Monitoring the spread of myxoma virus in rabbit Oryctolagus cuniculus populations on the southern tablelands of New South Wales, Australia. I. Natural occurrence of myxomatosis.
Merchant JC; Kerr PJ; Simms NG; Robinson AJ
Epidemiol Infect; 2003 Feb; 130(1):113-21. PubMed ID: 12613753
[TBL] [Abstract][Full Text] [Related]
39. Effects of myxoma virus and rabbit hemorrhagic disease virus on the physiological condition of wild European rabbits: Is blood biochemistry a useful monitoring tool?
Pacios-Palma I; Santoro S; Bertó-Moran A; Moreno S; Rouco C
Res Vet Sci; 2016 Dec; 109():129-134. PubMed ID: 27892861
[TBL] [Abstract][Full Text] [Related]
40. Myxomatosis: the virulence of field strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high resistance to myxomatosis.
Edmonds JW; Nolan IF; Shepherd RC; Gocs A
J Hyg (Lond); 1975 Jun; 74(3):417-8. PubMed ID: 1056963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
